Showing results (1-10 of 92) with videos related to
Sort By:
Pageof 10
Annales De Medecine Interne|August 3, 2000
[Non-nucleoside reverse transcriptase inhibitors]V Joly, P YeniPresse Medicale (Paris, France : 1983)|January 14, 1995
[Treatment of HIV infection with nucleoside analogs: present status]V Joly, P YeniLa Revue Du Praticien|December 1, 1999
[Treatment strategies and surveillance of chronic HIV infection in adults]V Joly, P YeniThe Journal of Pharmacology and Experimental Therapeutics|October 1, 1990
Interactions of free and liposomal amphotericin B with renal proximal tubular cells in primary cultureV Joly, L Saint-Julien, C Carbon, et al.The Journal of Infectious Diseases|November 1, 1994
In vivo activity of interferon-gamma in combination with amphotericin B in the treatment of experimental cryptococcosisV Joly, L Saint-Julien, C Carbon, et al.Presse Medicale (Paris, France : 1983)|May 30, 1992
[Choice and monitoring of the treatment of systemic mycoses. Value and limitations of in vitro tests]O Eloy, V Joly, J C Ghnassia, et al.Antimicrobial Agents and Chemotherapy|February 1, 1992
Influence of phospholipid/amphotericin B ratio and phospholipid type on in vitro renal cell toxicities and fungicidal activities of lipid-associated amphotericin B formulationsV Joly, J Bolard, L Saint-Julien, et al.Antimicrobial Agents and Chemotherapy|December 1, 1992
Activity of MS-8209, a nonester amphotericin B derivative, in treatment of experimental systemic mycosesL Saint-Julien, V Joly, M Seman, et al.Nephron|January 1, 1997
Evaluation of renal acidification in HIV-infected patients with hypergammaglobulinemiaM L Seux-Levieil, V Joly, P Yeni, et al.Antimicrobial Agents and Chemotherapy|July 1, 1991
Limited protection by small unilamellar liposomes against the renal tubular toxicity induced by repeated amphotericin B infusions in ratsP Longuet, V Joly, P Amirault, et al.Pageof 10